Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China · Delayed Price · Currency is CNY 24.65
+0.53 (2.20%)
Aug 11, 2026, 11:25 AM CST
SHA:600196 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 42,315 | 41,662 | 41,067 | 41,400 | 43,952 | 39,011 |
Revenue Growth | 4.92% | 1.45% | -0.80% | -5.81% | 12.66% | 28.72% |
Gross Profit Gross Profit Growth | 21,290 | 20,784 | 19,641 | 19,683 | 20,696 | 18,717 |
Operating Income Operating Income Growth | 2,957 | 2,790 | 2,974 | 1,184 | 3,420 | 2,537 |
Net Income Net Income Growth | 3,477 | 3,371 | 2,770 | 2,385 | 3,731 | 4,729 |
Earnings Per Share EPS Growth | 1.31 | 1.27 | 1.04 | 0.89 | 1.43 | 1.85 |
EPS Growth | 19.43% | 22.44% | 16.10% | -37.52% | -22.50% | 29.10% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 29,953 | 29,274 | 30,693 | 31,767 | 29,212 |
Medical Devices and Medical Diagnosis Medical Devices and Medical Diagnosis Growth | 4,340 | 4,352 | 4,444 | 7,254 | 5,973 |
Health care Service Health care Service Growth | 7,395 | 7,673 | 6,715 | 6,158 | 4,188 |
Others Others Growth | 209.29 | 191.7 | 151.06 | 156.25 | 81.8 |
Eliminations Eliminations Growth | -235.86 | -423.58 | -603.39 | -1,383 | -444.36 |
Total Total Growth | 41,662 | 41,067 | 41,400 | 43,952 | 39,011 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,293 | 15,358 | 16,120 | 15,582 | 17,170 | 14,558 |
Total Debt Total Debt Growth | 39,532 | 36,427 | 36,021 | 35,035 | 30,191 | 25,454 |
Net Cash (Debt) Net Cash Growth | -24,239 | -21,069 | -19,901 | -19,453 | -13,021 | -10,896 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.16 | -7.96 | -7.45 | -7.29 | -4.99 | -4.25 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,306 | 5,213 | 4,477 | 3,414 | 4,218 | 3,938 |
Capital Expenditures CapEx Growth | -4,421 | -4,448 | -4,410 | -5,337 | -5,889 | -4,973 |
Free Cash Flow Free Cash Flow Growth | 884.92 | 764.78 | 66.79 | -1,922 | -1,671 | -1,035 |
Free Cash Flow Growth | 159.50% | 1045.04% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.31% | 49.89% | 47.83% | 47.54% | 47.09% | 47.98% |
Operating Margin | 6.99% | 6.70% | 7.24% | 2.86% | 7.78% | 6.50% |
Pretax Margin | 12.10% | 12.27% | 10.15% | 7.89% | 10.41% | 15.49% |
Profit Margin | 8.22% | 8.09% | 6.74% | 5.76% | 8.49% | 12.12% |
FCF Margin | 2.09% | 1.84% | 0.16% | -4.64% | -3.80% | -2.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.390 | 0.390 | 0.320 | 0.270 | 0.420 | 0.560 |
Dividend Per Share Growth | 21.88% | 21.88% | 18.52% | -35.71% | -25.00% | 30.23% |
Dividend Yield | 1.64% | 1.50% | 1.33% | 1.12% | 1.26% | 1.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.41 | 19.31 | 21.57 | 25.82 | 23.30 | 24.08 |
Forward PE | 20.02 | 34.77 | 21.15 | 21.49 | 19.36 | 20.43 |
P/FCF Ratio | 66.16 | 85.12 | 894.58 | - | - | - |
PS Ratio | 1.38 | 1.56 | 1.46 | 1.49 | 1.98 | 2.92 |